Drug substance maker raises prices due to energy crisis; SpectronRX gets $85Mnews2026-04-02T14:43:53+00:00April 2nd, 2026|Endpoints News|
Trump is preparing 100% tariffs on some drugmakers, documents shownews2026-04-02T14:04:53+00:00April 2nd, 2026|Endpoints News|
Making custom CRISPR therapies could be harder than initially thoughtnews2026-04-01T19:40:47+00:00April 1st, 2026|Endpoints News|
Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factorynews2026-04-01T16:39:35+00:00April 1st, 2026|Endpoints News|
FDA delays decision on Orca Bio cell therapy after filing more manufacturing datanews2026-04-01T12:00:29+00:00April 1st, 2026|Endpoints News|
Samsung Bio union workers threaten strike over pay, disclosure of employee datanews2026-03-30T17:44:16+00:00March 30th, 2026|Endpoints News|
FDA approves Novo Nordisk’s once-weekly insulinnews2026-03-27T13:43:46+00:00March 27th, 2026|Endpoints News|
UCB picks Georgia for $2B biologics site; AbbVie exec visits China news2026-03-26T16:36:26+00:00March 26th, 2026|Endpoints News|
Novartis to invest $480M in China following AstraZeneca and Lilly pledgesnews2026-03-23T18:40:53+00:00March 23rd, 2026|Endpoints News|
FDA posts photos of Indian drugmaking facility cited in warning letternews2026-03-23T17:13:29+00:00March 23rd, 2026|Endpoints News|
